comparemela.com

Tania Corbett News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Climate-fuelled La Niña in East Africa will drive millions into hunger - Oxfam - Ethiopia

Climate-fuelled La Niña in East Africa will drive millions into hunger - Oxfam Format Over 50 million people are in need of immediate food assistance in the Horn East and Central Africa, with numbers expected to rise significantly as the region braces for harsh, climate fuelled La Niña conditions, said Oxfam today. The warning comes as world leaders prepare to meet for a virtual Climate Ambition Summit. Starting in mid-December, South Sudan, Somalia, Ethiopia, Kenya, Tanzania, Rwanda, and Uganda are likely to suffer from below average rainfall as a result of a strong La Niña, which could result in millions more people going hungry in 2021.

Sanofi/GSK vaccine delay a bitter blow for world s poorest countries - Oxfam

Sanofi/GSK vaccine delay a bitter blow for world’s poorest countries - Oxfam 11 December, 2020 - 17:10 Country: World Source: Oxfam Responding to today’s announcement that the Sanofi/GSK vaccine will not be ready until the end of 2021, Oxfam’s Global Health and Gender Equality Officer, Julia Heres Garcia said: “The delay is a bitter blow for poorer nations given Sanofi-GSK was set to provide nearly one third of COVAX doses – the global vaccine purchasing facility upon which many of the poorest countries depend. “Even without this delay COVAX had only secured enough doses to vaccinate 1 in 10 people in many of the poorest countries by the end of next year, while rich countries had enough to vaccinate their entire populations nearly 3 times over.

Sanofi/GSK vaccine delay a bitter blow for world s poorest countries - Oxfam - World

Sanofi/GSK vaccine delay a bitter blow for world’s poorest countries - Oxfam Format 11 Dec 2020 Responding to today’s announcement that the Sanofi/GSK vaccine will not be ready until the end of 2021, Oxfam’s Global Health and Gender Equality Officer, Julia Heres Garcia said: “The delay is a bitter blow for poorer nations given Sanofi-GSK was set to provide nearly one third of COVAX doses – the global vaccine purchasing facility upon which many of the poorest countries depend. “Even without this delay COVAX had only secured enough doses to vaccinate 1 in 10 people in many of the poorest countries by the end of next year, while rich countries had enough to vaccinate their entire populations nearly 3 times over.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.